HomeNewsIndiaCoronavirus pandemic | Pidilite to contribute Rs 25 cr towards COVID-19 relief funds

Coronavirus pandemic | Pidilite to contribute Rs 25 cr towards COVID-19 relief funds

This contribution will be made to the central as well as other emergency state relief funds, the company said in a statement.

April 13, 2020 / 14:10 IST
Story continues below Advertisement

Pidilite Industries on Monday said it will contribution of Rs 25 crore towards relief funds to fight the coronavirus pandemic. This contribution will be made to the central as well as other emergency state relief funds, the company said in a statement.

COVID-19 pandemic LIVE updates

Story continues below Advertisement

Pidilite Industries Ltd Managing Director Bharat Puri said, “We stand in solidarity with the people of India and our government's efforts to overcome this unprecedented pandemic."

He further said that the company will continue to care for the health and well-being of its partners and employees while constructively supporting the various relief efforts announced by the government.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show